Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Burkitt Lymphoma
100%
Pediatric
44%
Chronic Lymphocytic Leukemia
37%
Forkhead Box Protein O1 (FOXO1)
37%
CD34+
34%
BCR-ABL
30%
Lymphoma
30%
Tumor Protein p53 (TP53)
28%
Chronic Myeloid Leukaemia Cells
26%
Leukemia
26%
Chronic Myeloid Leukemia
25%
Adverse Outcomes
21%
DDX3X
20%
Genomic Classification
18%
Apoptosis-inducing Activity
18%
DAP-kinase
18%
Fine Needle Aspirate
18%
Copy number Analysis
18%
Protein Kinase 2
18%
Molecular Markers
18%
Degraded DNA
18%
Classification Model
18%
High-resolution
18%
Risk Stratification
18%
ADH1
18%
Drug Delivery Strategies
18%
Potential Stem Cell
18%
TP53 Abnormalities
18%
Low Input
18%
Identify Risk
18%
Single-cell Whole-genome Sequencing
18%
Pediatric Hodgkin Lymphoma
18%
Childhood Medulloblastoma
18%
Genomic Abnormalities
18%
Single-cell DNA Sequencing
18%
Evolutionary Trajectory
18%
Clonal Complexity
18%
Prognostic Marker
18%
Scanning Imaging
18%
Confocal Laser Scanning
18%
Stem Cell-derived
18%
Leukemic Stem Cells
18%
Targeted Drug Delivery
18%
Treatment Resistance
18%
Imatinib Mesylate
18%
Entrapment
18%
Leptomycin B
18%
BACH2
18%
RNA Helicase
18%
Lymphomagenesis
18%
Medicine and Dentistry
Burkitt's Lymphoma
79%
Pediatrics
75%
Genetics
66%
Childhood Cancer
28%
Risk Stratification
22%
Adverse Outcome
22%
Leukemia Cell
22%
Non-Hodgkin Lymphoma
22%
B Cell
20%
Biological Marker
20%
Imatinib
18%
Leptomycin B
18%
Chronic Myelogenous Leukemia
18%
Paneth Cell
18%
Cell Junction
18%
Confocal Laser Scanning Microscopy
18%
Stem Cell Self-Renewal
18%
B-Cell Chronic Lymphocytic Leukemia
18%
Chromosome Deletion
18%
Chromosome 7
18%
Goblet Cell
18%
High Risk Population
18%
Clinical Trial
18%
Tight Junction
18%
Cell Culture
18%
Caco-2
18%
Caco-2 Cell Line
18%
Gut
18%
Epithelial Cell
18%
Intestinal Epithelium
18%
Clinical Management
18%
Cancer Cell
18%
Colon Carcinoma
18%
Chemoimmunotherapy
13%
Dasatinib
12%
Nilotinib
12%
Supportive Care
9%
Health Care Cost
9%
Chronic Lymphocytic Leukemia
7%
Philadelphia 1 Chromosome
6%
Antiapoptotic
6%
Tyrosine-Kinase Inhibitor
6%
Protein Tyrosine Kinase
6%
Oncoprotein
6%
Signal Transduction
6%
Phosphotransferase
6%
Hematopoietic Cell
6%
Stem Cell
6%
Clinical Significance
5%
Biochemistry, Genetics and Molecular Biology
Kinase
25%
Phosphotransferase
25%
Programmed Cell Death
23%
Pediatrics
22%
B Cell
21%
Protein Kinase B
21%
Genetic Marker
18%
RNA Helicase
18%
DNA Sequence
18%
Protein Biosynthesis
18%
Whole Genome Sequencing
18%
Protein Kinases
18%
Imatinib
18%
Vasopressin
18%
Chromosome 7
18%
CD34
18%
Clinical Trial
18%
Prognostic Biomarker
18%
Degraded DNA
18%
Dexamethasone
18%
Myeloid
18%
Cancer Genomics
18%
Leptomycin
18%
Human Induced Pluripotent Stem Cell
18%
Genomics
18%
Copy Number Analysis
18%
FOXO1
18%
Nilotinib
12%
Dasatinib
12%
RNA
9%
Chromosome 6
9%
Tumor Initiation
9%
Y Chromosome
9%
Cooperation
9%
Biogenesis
9%
High Risk Population
9%
Messenger RNA
9%
CDH2
9%
Signal Transduction
8%
Hematopoietic Cell
6%
Philadelphia Chromosome
6%
Cytogenetics
6%
Receptor Tyrosine Kinase
6%
Stem Cell
6%
Tyrosine Kinase Inhibitor
6%
Tyrosine Kinase
6%
Cell Proliferation
5%